Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Candida albicans Augments Staphylococcus aureus Virulence by Engaging the Staphylococcal agr Quorum Sensing System.

Todd OA, Fidel PL Jr, Harro JM, Hilliard JJ, Tkaczyk C, Sellman BR, Noverr MC, Peters BM.

MBio. 2019 Jun 4;10(3). pii: e00910-19. doi: 10.1128/mBio.00910-19.

2.

Spectrum of Trained Innate Immunity Induced by Low Virulence Candida Species Against Lethal Polymicrobial Intra-Abdominal Infection.

Lilly EA, Yano J, Esher SK, Hardie E, Fidel PL Jr, Noverr MC.

Infect Immun. 2019 May 13. pii: IAI.00348-19. doi: 10.1128/IAI.00348-19. [Epub ahead of print]

3.

Candida/Staphylococcal Polymicrobial Intra-Abdominal Infection: Pathogenesis and Perspectives for a Novel Form of Trained Innate Immunity.

Esher SK, Fidel PL Jr, Noverr MC.

J Fungi (Basel). 2019 May 9;5(2). pii: E37. doi: 10.3390/jof5020037. Review.

4.

Questions remain regarding the presence of fungal species biofilm in women with vulvovaginal candidiasis.

Noverr MC, Fidel PL Jr.

Am J Obstet Gynecol. 2019 Apr 25. pii: S0002-9378(19)30582-4. doi: 10.1016/j.ajog.2019.04.017. [Epub ahead of print] No abstract available.

PMID:
31029662
5.

Candida glabrata Has No Enhancing Role in the Pathogenesis of Candida-Associated Denture Stomatitis in a Rat Model.

Yano J, Yu A, Fidel PL Jr, Noverr MC.

mSphere. 2019 Apr 3;4(2). pii: e00191-19. doi: 10.1128/mSphere.00191-19.

6.

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes.

Yano J, Sobel JD, Nyirjesy P, Sobel R, Williams VL, Yu Q, Noverr MC, Fidel PL Jr.

BMC Womens Health. 2019 Mar 29;19(1):48. doi: 10.1186/s12905-019-0748-8.

7.

Erratum for Savage et al., "Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis".

Savage KA, Parquet MDC, Allan DS, Davidson RJ, Holbein BE, Lilly EA, Fidel PL Jr.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e02508-18. doi: 10.1128/AAC.02508-18. Print 2019 Feb. No abstract available.

8.

Student and faculty perspectives of a faculty-student mentoring programme in a dental school.

Mascarenhas F, Townsend J, Caballero P, Yu Q, Fidel PL Jr.

Eur J Dent Educ. 2019 May;23(2):184-189. doi: 10.1111/eje.12418. Epub 2019 Feb 7.

PMID:
30632253
9.
10.
11.

Immune Protection against Lethal Fungal-Bacterial Intra-Abdominal Infections.

Lilly EA, Ikeh M, Nash EE, Fidel PL Jr, Noverr MC.

MBio. 2018 Jan 16;9(1). pii: e01472-17. doi: 10.1128/mBio.01472-17.

12.

Prostaglandin E2 Receptor Antagonist with Antimicrobial Activity against Methicillin-Resistant Staphylococcus aureus.

Ikeh MAC, Fidel PL Jr, Noverr MC.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e01920-17. doi: 10.1128/AAC.01920-17. Print 2018 Mar.

13.

Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: "Neutrophil Anergy".

Yano J, Peters BM, Noverr MC, Fidel PL Jr.

Infect Immun. 2018 Feb 20;86(3). pii: e00684-17. doi: 10.1128/IAI.00684-17. Print 2018 Mar. Review.

14.

Reply to "Chronic Vaginal Candidiasis Is Achievable in Outbred CD-1 Mice".

Yano J, Noverr MC, Fidel PL Jr.

MBio. 2017 Oct 24;8(5). pii: e01736-17. doi: 10.1128/mBio.01736-17. No abstract available.

15.
16.

Synthesis, Antifungal Activity, and Biocompatibility of Novel 1,4-Diazabicyclo[2.2.2]Octane (DABCO) Compounds and DABCO-Containing Denture Base Resins.

Herman JL, Wang Y, Lilly EA, Lallier TE, Peters BM, Hamdan S, Xu X, Fidel PL Jr, Noverr MC.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02575-16. doi: 10.1128/AAC.02575-16. Print 2017 Apr.

17.

Transcription Factors Efg1 and Bcr1 Regulate Biofilm Formation and Virulence during Candida albicans-Associated Denture Stomatitis.

Yano J, Yu A, Fidel PL Jr, Noverr MC.

PLoS One. 2016 Jul 25;11(7):e0159692. doi: 10.1371/journal.pone.0159692. eCollection 2016.

18.

Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Jabra-Rizk MA, Kong EF, Tsui C, Nguyen MH, Clancy CJ, Fidel PL Jr, Noverr M.

Infect Immun. 2016 Sep 19;84(10):2724-39. doi: 10.1128/IAI.00469-16. Print 2016 Oct. Review.

19.

A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response.

Nash EE, Peters BM, Lilly EA, Noverr MC, Fidel PL Jr.

PLoS One. 2016 Jan 25;11(1):e0147969. doi: 10.1371/journal.pone.0147969. eCollection 2016.

20.

Morphology-Independent Virulence of Candida Species during Polymicrobial Intra-abdominal Infections with Staphylococcus aureus.

Nash EE, Peters BM, Fidel PL, Noverr MC.

Infect Immun. 2015 Oct 19;84(1):90-8. doi: 10.1128/IAI.01059-15. Print 2016 Jan.

21.

ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis.

Luna-Tapia A, Peters BM, Eberle KE, Kerns ME, Foster TP, Marrero L, Noverr MC, Fidel PL Jr, Palmer GE.

Eukaryot Cell. 2015 Oct;14(10):1006-16. doi: 10.1128/EC.00116-15. Epub 2015 Jul 31.

22.

Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis.

Garvey EP, Hoekstra WJ, Schotzinger RJ, Sobel JD, Lilly EA, Fidel PL Jr.

Antimicrob Agents Chemother. 2015 Sep;59(9):5567-73. doi: 10.1128/AAC.00185-15. Epub 2015 Jun 29.

23.

Transcriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome.

Bruno VM, Shetty AC, Yano J, Fidel PL Jr, Noverr MC, Peters BM.

MBio. 2015 Apr 21;6(2). pii: e00182-15. doi: 10.1128/mBio.00182-15.

24.

Morphogenesis is not required for Candida albicans-Staphylococcus aureus intra-abdominal infection-mediated dissemination and lethal sepsis.

Nash EE, Peters BM, Palmer GE, Fidel PL, Noverr MC.

Infect Immun. 2014 Aug;82(8):3426-35. doi: 10.1128/IAI.01746-14. Epub 2014 Jun 2.

25.

Dental rounds: an evolving process of curriculum integration at the LSU School of Dentistry.

Townsend JA, Bates ML, Rodriguez TE, Andrieu SC, Hagan JL, Cheramie TJ, Smith CA, Leigh JE, Fidel PL Jr.

J Dent Educ. 2014 May;78(5):796-802.

26.

Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection.

Wozniak KL, Hole CR, Yano J, Fidel PL Jr, Wormley FL Jr.

Microbiology. 2014 Jul;160(Pt 7):1440-52. doi: 10.1099/mic.0.073445-0. Epub 2014 Apr 23.

27.

Candida vaginitis: when opportunism knocks, the host responds.

Peters BM, Yano J, Noverr MC, Fidel PL Jr.

PLoS Pathog. 2014 Apr 3;10(4):e1003965. doi: 10.1371/journal.ppat.1003965. eCollection 2014 Apr. Review. No abstract available.

28.
29.

Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis.

Peters BM, Palmer GE, Nash AK, Lilly EA, Fidel PL Jr, Noverr MC.

Infect Immun. 2014 Feb;82(2):532-43. doi: 10.1128/IAI.01417-13. Epub 2013 Nov 11.

30.

Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis.

Fazly A, Jain C, Dehner AC, Issi L, Lilly EA, Ali A, Cao H, Fidel PL Jr, Rao RP, Kaufman PD.

Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13594-9. doi: 10.1073/pnas.1305982110. Epub 2013 Jul 31.

31.

Engineering Candida albicans to secrete a host immunomodulatory factor.

Johnston DA, Yano J, Fidel PL Jr, Eberle KE, Palmer GE.

FEMS Microbiol Lett. 2013 Sep;346(2):131-9. doi: 10.1111/1574-6968.12211. Epub 2013 Jul 23.

32.

Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition.

Hong E, Dixit S, Fidel PL, Bradford J, Fischer G.

J Low Genit Tract Dis. 2014 Jan;18(1):31-8. doi: 10.1097/LGT.0b013e318287aced.

PMID:
23760143
33.

Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals.

Khan SA, Fidel PL Jr, Thunayyan AA, Varlotta S, Meiller TF, Jabra-Rizk MA.

J AIDS Clin Res. 2013 Mar 5;4(193). pii: 1000193.

34.

The acute neutrophil response mediated by S100 alarmins during vaginal Candida infections is independent of the Th17-pathway.

Yano J, Kolls JK, Happel KI, Wormley F, Wozniak KL, Fidel PL Jr.

PLoS One. 2012;7(9):e46311. doi: 10.1371/journal.pone.0046311. Epub 2012 Sep 25.

35.

Development of a contemporary animal model of Candida albicans-associated denture stomatitis using a novel intraoral denture system.

Johnson CC, Yu A, Lee H, Fidel PL Jr, Noverr MC.

Infect Immun. 2012 May;80(5):1736-43. doi: 10.1128/IAI.00019-12. Epub 2012 Mar 5.

36.
37.

Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

Yano J, Noverr MC, Fidel PL Jr.

Cytokine. 2012 Apr;58(1):118-28. doi: 10.1016/j.cyto.2011.11.021. Epub 2011 Dec 17. Review.

38.

CD8 T cells and E-cadherin in host responses against oropharyngeal candidiasis.

Quimby K, Lilly EA, Zacharek M, McNulty K, Leigh JE, Vazquez JE, Fidel PL Jr.

Oral Dis. 2012 Mar;18(2):153-61. doi: 10.1111/j.1601-0825.2011.01856.x. Epub 2011 Sep 30.

39.

New approaches to Candida and oral mycotic infections: Workshop 2A.

McCullough M, Patton LL, Coogan M, Fidel PL Jr, Komesu M, Ghannoum M, Leigh JE.

Adv Dent Res. 2011 Apr;23(1):152-8. doi: 10.1177/0022034511400912.

PMID:
21441497
40.

HIV infection and specific mucosal immunity: workshop 4B.

Challacombe SJ, Fidel PL Jr, Tugizov S, Tao L, Wahl SM.

Adv Dent Res. 2011 Apr;23(1):142-51. doi: 10.1177/0022034511400222.

PMID:
21441496
41.

Innate immunity including epithelial and nonspecific host factors: workshop 1B.

Weinberg A, Naglik JR, Kohli A, Tugizov SM, Fidel PL Jr, Liu Y, Herzberg M.

Adv Dent Res. 2011 Apr;23(1):122-9. doi: 10.1177/0022034511399917.

PMID:
21441493
42.

Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis.

Fidel PL Jr.

Adv Dent Res. 2011 Apr;23(1):45-9. doi: 10.1177/0022034511399284. Review.

43.

Fabrication of a multi-applicable removable intraoral denture system for rodent research.

Lee H, Yu A, Johnson CC, Lilly EA, Noverr MC, Fidel PL Jr.

J Oral Rehabil. 2011 Sep;38(9):686-90. doi: 10.1111/j.1365-2842.2011.02206.x. Epub 2011 Feb 17.

44.

Prospects for development of a vaccine to prevent and control vaginal candidiasis.

Fidel PL Jr, Cutler JE.

Curr Infect Dis Rep. 2011 Feb;13(1):102-7. doi: 10.1007/s11908-010-0143-y.

45.

Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis.

Yano J, Lilly E, Barousse M, Fidel PL Jr.

Infect Immun. 2010 Dec;78(12):5126-37. doi: 10.1128/IAI.00388-10. Epub 2010 Sep 7.

46.

Candida albicans forms biofilms on the vaginal mucosa.

Harriott MM, Lilly EA, Rodriguez TE, Fidel PL, Noverr MC.

Microbiology. 2010 Dec;156(Pt 12):3635-3644. doi: 10.1099/mic.0.039354-0. Epub 2010 Aug 12.

47.

Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety.

Lilly EA, Yano J, Fidel PL Jr.

Mol Oral Microbiol. 2010 Aug;25(4):293-304. doi: 10.1111/j.2041-1014.2010.00579.x.

48.

Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection.

Peters BM, Zhu J, Fidel PL Jr, Scheper MA, Hackett W, El Shaye S, Jabra-Rizk MA.

FEMS Yeast Res. 2010 Aug 1;10(5):597-604. doi: 10.1111/j.1567-1364.2010.00632.x. Epub 2010 Apr 13.

49.

Candidacidal activity of synthetic peptides based on the antimicrobial domain of the neutrophil-derived protein, CAP37.

Pereira HA, Tsyshevskaya-Hoover I, Hinsley H, Logan S, Nguyen M, Nguyen TT, Pohl J, Wozniak K, Fidel PL.

Med Mycol. 2010 Mar;48(2):263-72. doi: 10.1080/13693780903081976.

50.

Supplemental Content

Loading ...
Support Center